Literature DB >> 10051460

Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.

E Lotterer1, A Wengert, W E Fleig.   

Abstract

The aim of this prospective, nonrandomized study was to assess the short- and long-term effects of transjugular intrahepatic portosystemic shunt (TIPS) on hepatic and systemic hemodynamics and on gastroesophageal collateral flow in patients with cirrhosis and failure of chronic sclerotherapy. Cardiac output (CO), free and wedged pulmonary artery pressure (FPAP and WPAP), systemic vascular resistance (SVR), azygos venous blood flow (AzVBF), and the relative (portal minus vena cava) pressure in the portal vein (rel.PP) were determined immediately before, 30 minutes, 1 week, 3 months, and 1 year after TIPS implantation in 21 patients with alcoholic and biliary cirrhosis with repeated bleeding from esophageal varices despite chronic sclerotherapy. TIPS was inserted when patients were in a stable hemodynamic condition. Palmaz stents were dilated to a 10-mm to 14-mm diameter until gastroesophageal collaterals were no longer visible on direct splenoportography. Relative portal pressure decreased from 21 +/- 5 mm Hg to 11 +/- 5 mm Hg 30 minutes after the procedure (P <.001). CO increased from 7.1 +/- 1.5 L/min at baseline to 8.9 +/- 2.0 L/min (P <.005) at 30 minutes, 8.2 +/- 2.0 L/min (P <. 01) at 1 week, and 8.0 +/- 2.0 L/min (P <.01) at 3 months after TIPS, and returned to 7.2 +/- 1.3 L/min (ns) after 1 year. Before TIPS, SVR was 990 +/- 285 dyne. sec. cm-5 and decreased to 856 +/- 252 dyne. sec. cm-5 (P <.05) and 866 +/- 267 dyne. sec. cm-5 (P <.05) at 30 minutes and 1 week after the procedure, and increased again to 903 +/- 208 dyne. sec. cm-5 (ns) and 1,016 +/- 260 dyne. sec. cm-5 (ns) at 3 months and 1 year, respectively. AzVBF continuously decreased from 474 +/- 138 mL/min before TIPS to 335 +/- 116 mL/min, 289 +/- 147 mL/min, 318 +/- 157 mL/min, and 250 +/- 104 mL/min (all P <.005) at 30 minutes, 1 week, 3 months, and 1 year after TIPS. Portal decompression after TIPS is associated with a significant increase of CO for at least 3 months, which is only partly explained by a transient decrease of SVR. After 1 year, CO had returned to baseline levels. Despite an immediate decrease in portal pressure, the reduction of blood flow through gastroesophageal collaterals is delayed and not complete before 1 year after TIPS. In contrast to previous short-term observations, TIPS does not seem to cause long-term aggravation of the hyperkinetic circulation in patients with cirrhosis.

Entities:  

Mesh:

Year:  1999        PMID: 10051460     DOI: 10.1002/hep.510290302

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

Review 1.  Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options.

Authors:  Brian Erly; William D Carey; Baljendra Kapoor; J Mark McKinney; Mathew Tam; Weiping Wang
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

Review 2.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

3.  Can an incomplete stent expansion modulate the effects of TIPS?

Authors:  Oliviero Riggio; Stefania Angeloni; Lorenzo Ridola; Plinio Rossi
Journal:  J Gastroenterol       Date:  2010-01-05       Impact factor: 7.527

4.  Pulmonary arterial hypertension: an unusual cause of portal hypertension.

Authors:  Enric Reverter; Susana Seijo; Jaime Bosch
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

Review 5.  Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes.

Authors:  Francesco Vizzutti; Filippo Schepis; Umberto Arena; Fabrizio Fanelli; Stefano Gitto; Silvia Aspite; Laura Turco; Gabriele Dragoni; Giacomo Laffi; Fabio Marra
Journal:  Intern Emerg Med       Date:  2020-01-09       Impact factor: 3.397

6.  Diagnosis and therapy of ascites in liver cirrhosis.

Authors:  Erwin Biecker
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

7.  Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome.

Authors:  Graciela Martinez-Palli; Britt B Drake; Joan-Carles Garcia-Pagan; Joan-Albert Barbera; Miguel R Arguedas; Robert Rodriguez-Roisin; Jaume Bosch; Michael B Fallon
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

8.  Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.

Authors:  Harjit K Bhogal; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2011-06-21       Impact factor: 11.382

9.  High Flow-Mediated Vasodilatation Predicts Pulmonary Edema in Liver Transplant Patients.

Authors:  Shyh-Ming Chen; Chao-Long Chen; Han-Tan Chai; Chee-Chien Yong; Hsien-Wen Hsu; Yu-Fan Cheng; Morgan Fu; Yu-Tung Anton Huang; Chi-Ling Hang
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

10.  Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis.

Authors:  Andrew S Allegretti; Guillermo Ortiz; Jie Cui; Julia Wenger; Ishir Bhan; Raymond T Chung; Ravi I Thadhani; Zubin Irani
Journal:  Am J Kidney Dis       Date:  2016-03-16       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.